Group 1: 恒瑞医药 - Company announced that its subsidiary received approval for clinical trials of HRS9531 injection, a novel dual agonist targeting GIPR and GLP-1R, aimed at treating metabolic dysfunction-related fatty liver disease (MASH) [1] - HRS9531 injection is expected to improve blood sugar levels and reduce weight by regulating glucose and lipid metabolism, suppressing appetite, and enhancing insulin sensitivity [1] - There are currently no similar drugs approved globally for the MASH indication, and the total R&D investment for HRS9531 has reached approximately 519 million yuan [1] Group 2: 青岛港 - Company announced the termination of its cash acquisition of 100% equity in Rizhao Port Oil Products Terminal Co., Ltd. and 50% equity in Rizhao Shihua Oil Terminal Co., Ltd. due to significant impacts from Rizhao Shihua being listed on the U.S. Specially Designated Nationals list [2] - The termination agreement was signed on December 12, 2025, and will not incur any breach of contract or other liabilities, nor will it adversely affect the company's operations or financial status [2] Group 3: 隆盛科技 - Company plans to invest approximately 350 million yuan to establish a humanoid intelligent robot innovation center in Wuxi, with a focus on R&D and industrialization of humanoid robots [3] - The project will involve a total investment of about 350 million yuan, with the company covering around 200 million yuan for land and construction, while its subsidiary will invest approximately 150 million yuan for the center's operation [3] Group 4: *ST沪科 - Company received a notice from the China Securities Regulatory Commission regarding an investigation into suspected violations of information disclosure laws [4] - The company stated that its production and operations are normal and that the investigation will not have a significant impact on its management [4] Group 5: 永鼎股份 - Company clarified that it does not directly manufacture controllable nuclear fusion devices, despite being listed as a related concept stock [5] - The revenue from its subsidiary related to this area accounts for less than 1% of the company's total revenue and is currently operating at a loss [5] - The controlling shareholder reduced its stake by 1.336 million shares during a period of abnormal stock trading [5] Group 6: 亚翔集成 - Company announced that its shareholder EVER CREATIVE reduced its stake by 414,000 shares on December 11, 2025, amid significant stock price fluctuations [6] - The stock experienced a cumulative price deviation exceeding 20% over two consecutive trading days [6] Group 7: 恩捷股份 - Company plans to acquire 100% of Qingdao Zhongke Hualian New Materials Co., Ltd. through a share issuance and will resume trading on December 15 [8] Group 8: 芯原股份 - Company announced the termination of its plan to acquire 97% of Chipwise Technology due to discrepancies between the management's core demands and market conditions [9] - The decision was made to protect the interests of the company and its shareholders [9]

Core Viewpoint - Enjie Co., Ltd. plans to acquire 100% of Qingdao Zhongke Hualian New Materials Co., Ltd. through a share issuance, aiming to enhance its product matrix and reduce production costs [1][3]. Group 1: Company Overview - Enjie Co., Ltd. is a leading supplier of lithium battery separators, primarily serving the electric vehicle battery manufacturing sector, 3C products, and energy storage [2]. - The company has established a strong presence in the global supply chain of major lithium battery manufacturers, including CATL, BYD, and Panasonic, maintaining the largest market share for several consecutive years [2]. Group 2: Acquisition Details - The acquisition involves issuing shares at a price of 34.38 yuan per share, with the specific transaction price yet to be determined as the audit and evaluation of the target company are still ongoing [1]. - The acquisition is seen as a strategic move to transition from product competition to a full supply chain system competition, indicating a shift in the industry towards higher concentration [3]. Group 3: Strategic Implications - The transaction will allow Enjie to utilize Zhongke Hualian's separator production equipment and technology, enabling the production of high-performance separator products and reducing operational costs [3]. - The acquisition is expected to facilitate overseas production line construction and mitigate supply chain risks, while also complementing the product matrix with Zhongke Hualian's Blue Ketu separator brand [3]. Group 4: Market Context - Recent communications from the company indicate that separator prices are influenced by supply and demand dynamics, with expectations for gradual recovery in pricing due to cautious industry expansion and increasing downstream demand [3]. - Prior to the acquisition announcement, Enjie's stock had a closing price of 55.35 yuan per share, with a total market capitalization of 54.37 billion yuan, and a cumulative increase of 14.08% over the previous 20 trading days [4].

Core Viewpoint - Enjie Co., Ltd. plans to acquire 100% of Qingdao Zhongke Hualian New Materials Co., Ltd. through a share issuance, with the stock resuming trading on December 15 [1] Group 1: Acquisition Details - The acquisition involves 63 counterparties, including Zhi Lipeng, Qingdao Zhongzhida, Chen Jichao, Yang Bo, and Yuan Jun [1] - The transaction is not expected to constitute a major asset restructuring, related party transaction, or restructuring listing [1] Group 2: Company Profile of Zhongke Hualian - Zhongke Hualian specializes in the R&D, production, and sales of complete production equipment and products for wet lithium-ion battery separators [1] - The main business includes the R&D, production, and sales of lithium battery separator equipment and separators, primarily serving lithium battery manufacturers and separator manufacturers [1] Group 3: Strategic Benefits - The transaction is expected to help the company expand its product matrix and utilize its own separator equipment to produce high-performance separator products [1] - It aims to leverage advanced process advantages, accelerate technology iteration, strengthen technical barriers, enhance supply chain stability, and improve production flexibility [1] - The acquisition is also intended to deepen customer binding and enhance global competitiveness [1]

责任编辑：山上 股票频道更多独家策划、专家专栏，免费查阅>> 格隆汇12月12日丨恩捷股份(002812.SZ)公布，经公司向深圳证券交易所申请，公司股票将于2025年12 月15日（星期一）开市起复牌。 ...

Group 1 - The company plans to acquire 100% of Zhongke Hualian's shares through a share issuance to 63 counterparties, while also raising matching funds from up to 35 qualified investors [1] - The target company has a market share of approximately 4.5% in the domestic wet lithium battery separator market for 2024, ranking sixth in the industry [1] - The acquisition is expected to enhance the company's existing separator product matrix and improve advanced capacity layout, leading to faster capacity increase and performance release [1] Group 2 - The target company is a leading domestic manufacturer of lithium battery separator production equipment, with over ten years of experience in developing complete production equipment [2] - The production line for wet lithium battery separators has received recognition as the first major technical equipment in the country, showcasing the target company's technological advantages [2] - Post-acquisition, the company will utilize the target's production equipment and technology to produce high-performance separators, thereby reducing production and operational costs [2]

Group 1 - The company plans to acquire 100% of Zhongke Hualian's shares through a share issuance to 63 counterparties, while also raising supporting funds by issuing shares to no more than 35 qualified investors [1] - The share issuance price for the asset purchase is set at 34.38 yuan per share, with the fundraising share issuance price not lower than 80% of the average trading price of the company's stock over the 20 trading days prior to the pricing benchmark [1] - Zhongke Hualian is a high-tech enterprise specializing in the R&D, production, and sales of wet lithium-ion battery separator production equipment and other polymer material production equipment, with major clients being lithium battery and separator manufacturers [1] Group 2 - Post-transaction, the company will utilize Zhongke Hualian's separator production equipment and corresponding production technology to manufacture high-performance separator products, thereby reducing production and operational costs [2] - The company, as the largest global supplier of lithium-ion battery separators, has maintained its market leadership for several years, with sufficient order demand and extensive sales channels to effectively promote the sales of Zhongke Hualian's separator products [2] - The stock of the company will resume trading on December 15, 2025 [3]

Group 1 - The company plans to acquire 100% of Zhongke Hualian's shares through a share issuance to 63 counterparties, with the specific transaction price yet to be determined as the audit and evaluation work is still ongoing [1] - Zhongke Hualian's brand, Lanketu, holds approximately 4.5% of the domestic market share in the wet lithium battery separator market, ranking sixth in the industry as of 2024 [1] - The acquisition is expected to enhance the company's existing separator product matrix, improve advanced capacity layout, and accelerate capacity expansion and performance release if sufficient construction funds are secured [1] Group 2 - Zhongke Hualian is a leading domestic manufacturer of lithium battery separator production equipment, having developed a complete set of separator production equipment over more than ten years [2] - The technical advantages of Zhongke Hualian's separator production equipment include high annual production capacity per line, basic localization of core components, and the ability to quickly switch production lines [2] - Post-acquisition, the company will utilize Zhongke Hualian's production equipment and technology to produce high-performance separators, thereby reducing production and operational costs [2]

Core Viewpoint - The company plans to acquire 100% of Zhongke Hualian's shares through a share issuance and raise supporting funds, enhancing its capabilities in lithium-ion battery separator production [1][2]. Group 1: Acquisition Details - The company intends to issue shares to 63 parties, including Zhi Lipeng and Qingdao Zhongzhida, to purchase Zhongke Hualian's shares, with the specific transaction price yet to be determined [1]. - The share issuance price for the asset purchase is set at 34.38 yuan per share, while the price for raising supporting funds will not be lower than 80% of the average trading price over the last 20 trading days [1]. Group 2: Target Company Overview - Zhongke Hualian is a high-tech enterprise specializing in the R&D, production, and sales of wet lithium-ion battery separator production equipment and other polymer material production equipment [1]. - The target company has been a leading manufacturer of lithium battery separator production equipment in China since the successful debugging of its first production line in 2013, with significant technological advantages [1]. Group 3: Strategic Benefits - Post-acquisition, the company can utilize the target's production equipment and technology to produce high-performance separator products, thereby reducing production and operational costs [2]. - The company’s extensive experience and capacity in the lithium separator field will facilitate improvements and expansions in the target company's production capabilities [2]. - The target's products will complement the company's existing separator product matrix, enhancing production scale and efficiency [2].

Core Viewpoint - Enjie Co., Ltd. plans to acquire 100% of Qingdao Zhongke Hualian New Materials Co., Ltd. through a share issuance to 63 counterparties, with the specific transaction price yet to be determined [1] Group 1: Acquisition Details - The acquisition involves purchasing shares from Zhili Peng, Qingdao Zhongzhida, Chen Jichao, Yang Bo, Yuan Jun, and others [1] - The target company specializes in the R&D, production, and sales of wet lithium-ion battery separator production equipment and other polymer material production equipment [1] - The target company's main customers are lithium battery and lithium battery separator manufacturers [1] Group 2: Financial Aspects - The company will also raise supporting funds alongside the acquisition [1] - As of now, the auditing and evaluation work for the target company has not been completed [1] - The specific transaction price for the acquisition remains undetermined [1] Group 3: Stock Market Impact - The company's stock will resume trading on December 15, following the announcement [1]

每经AI快讯，12月12日，恩捷股份（002812）(002812.SZ)公告称，公司拟通过发行股份方式向郅立 鹏、青岛众智达投资有限公司、陈继朝、杨波、袁军等交易对方购买其所持有的青岛中科华联新材料股 份有限公司(简称"中科华联")100%的股份，并拟向不超过35名符合条件的特定对象发行股份募集配套资 金。股票将于12月15日起复牌。 ...